Sankey It
Loading...
Pfizer Inc. FY2022 income statement | Sankey It
Sankey It · PFE
Pfizer Inc. FY2022 income statement
USD · fiscal year ended 2022-12-31
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Pfizer Inc. FY2022 income statement
Flow diagram with 9 nodes and 8 flows for Pfizer Inc. FY2022 income statement. Values: Biopharma Segment US$99B, Revenue US$100.3B, Cost of Revenue US$38.2B, Gross Profit US$62.1B, Operating Expenses US$24.5B, Operating Income US$37.5B, Other Expense US$2.8B, Tax US$3.3B, Net Income US$31.4B.
Biopharma Segment
US$99B
+24% Y/Y
99% of revenue
Revenue
US$100.3B
+23% Y/Y
Cost of Revenue
(US$38.2B)
+11% Y/Y
38% of revenue
Gross Profit
US$62.1B
+32% Y/Y
62% margin
Operating Expenses
(US$24.5B)
-6% Y/Y
24% of revenue
Operating Income
US$37.5B
+81% Y/Y
37% margin
Other Expense
(US$2.8B)
3% of revenue
Tax
(US$3.3B)
+80% Y/Y
3% of revenue
Net Income
US$31.4B
+42% Y/Y
31% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen